Holen Sie sich die Stockscreener-App
1.70
1.73%
-0.03
Vorhandelsmarkt:
1.70
Invo Fertility Inc Aktie (IVF) Neueste Nachrichten
INVO Bioscience : Expands its Presence in Eurasia with New Distribution Agreements to Commercialize the INVOcell In Vivo Fertilization System - marketscreener.com
INVO Bioscience : Appoints Michael J. Campbell as COO & VP of Business Development - marketscreener.com
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 | IVF Stock News - GuruFocus
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 - The Manila Times
INVO Fertility Announces Live Investor Webcast: Management Hosting 1-on-1 Meetings at Lytham Conference - Stock Titan
INVO Bioscience, Inc. Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell Labeling - marketscreener.com
INVO Fertility Reports Q1 2025 Financial Results - TipRanks
INVO Fertility Announces First Quarter 2025 Financial Results | IVF Stock News - GuruFocus
INVO Fertility, Inc. Reports Q1 2025 Financial Results and Strategic Focus on Core Fertility Operations - Nasdaq
INVO Fertility Announces First Quarter 2025 Financial Results - The Manila Times
INVO Fertility, Inc. SEC 10-Q Report - TradingView
INVO Fertility Doubles Down on $22B Fertility Market After Q1 Growth, Divests Biotech Unit - Stock Titan
INVO Fertility Delays Q1 2025 10-Q Filing - TipRanks
INVO Fertility, Inc.Common Stock (NQ: IVF - FinancialContent
INVO Fertility (IVF) Announces Record Revenues and Strategic Focus on Fertility Services - GuruFocus
Top Premarket Gainers - marketscreener.com
INVO Fertility (IVF) Announces Record Revenues and Strategic Foc - GuruFocus
INVO Fertility Reports Strong Revenue Growth in 2024 - TipRanks
INVO Fertility Inc [IVF] Is Currently 48.45 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
INVO Fertility Inc (NASDAQ: IVF) Has Succeeded In Gaining Momentum In 2025, The Stock Is Down -75.41% YTD - Marketing Sentinel
There is no way INVO Fertility Inc (IVF) can keep these numbers up - Sete News
3 Penny Stocks to Watch Now, 5/1/25 - TipRanks
INVO Fertility inks deal, issues new warrants By Investing.com - Investing.com Nigeria
INVO BioScience (IVF) Reports Q4 Revenue Growth - GuruFocus
INVO Fertility Inc reports results for the quarter ended December 31Earnings Summary - TradingView
INVO Fertility Stock Is Surging Wednesday: What's Going On? - Benzinga
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher - Benzinga
INVO Fertility Announces 2024 Financial Results with 116% Annual - GuruFocus
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA - The Manila Times
Invo Fertility Announces 2024 Financial Results - marketscreener.com
INVO Fertility, Inc. Reports Record Revenue Growth in Q4 2024 and Full Year 2024 Financial Results - Nasdaq
INVO Fertility, Inc. SEC 10-K Report - TradingView
INVO Fertility, Inc. will Change its Ticker to IVF from NAYA - marketscreener.com
Sarasota fertility company changes name, ticker symbol - Business Observer
INVO Fertility (IVF) to Begin Trading Under New Ticker Symbol | NAYA Stock News - GuruFocus
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF” | NAY - GuruFocus
INVO Fertility To Begin Trading Under New Nasdaq Ticker Symbol 'IVF' - Nasdaq
INVO Fertility faces Nasdaq delisting over late 10-K filing - Investing.com
NAYA Biosciences Renames Itself INVO Fertility; Separates Oncology, Fertility Businesses - marketscreener.com
NAYA Biosciences to separate fertility & oncology businesses.... - Seeking Alpha
NAYA Biosciences Announces Strategic Decision to Separate - GlobeNewswire
Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023 - Seeking Alpha
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 - GlobeNewswire
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment - GlobeNewswire
NAYA Biosciences Announces Nomination of New Board Members - GlobeNewswire
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering - GlobeNewswire
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody - GlobeNewswire
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - GlobeNewswire
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma - GlobeNewswire
NAYANAYA Biosciences Latest Stock News & Market Updates - Stock Titan
INVO Bioscience changes name, trading symbol after merger - Business Observer
Sarasota fertility company completes merger with bioscience firm - Business Observer
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - marketscreener.com
Naya Biosciences - The Pharma Letter
Lakewood Ranch fertility company posts 2023 results, stock trading soars - Business Observer
NAYA buys Florida Biotechnologies for $20M to get hold of rare genetic disease drug - Fierce Biotech
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal - BioSpace
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies - PR Newswire
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger - PR Newswire
INVO to acquire NAYA to establish life science company - Pharmaceutical Technology
Why Is INVO Bioscience (INVO) Stock Up 325% Today? - InvestorPlace
INVO Closes Acquisition of Wisconsin Fertility Institute - PR Newswire
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023 - PR Newswire
INVO Bioscience’s INVOcell Device Receives FDA Approval for 5-Day Incubation in Fertility Treatment - Femtech Insider
INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek - PR Newswire
0.09%
2.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):